PCSK9 inhibitors and their role in high-risk patients in...

  • Main
  • 2016 / 02
  • PCSK9 inhibitors and their role in high-risk patients in...
Future Cardiology 2016 / 02

PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: alirocumab

Dahagam, Chanukya, Goud, Aditya, Abdelqader, Abdelhai, Hendrani, Aditya, Feinstein, Matthew J, Qamar, Arman, Joshi, Parag H, Swiger, Kristopher J, Byrne, Kathleen, Quispe, Renato, Jones, Steven R, Blu
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Future Cardiology
DOI:
10.2217/fca.15.88
Date:
February, 2016
File:
PDF, 1.66 MB
english, 2016
Conversion to is in progress
Conversion to is failed